文献检索/Expert Opinion on Drug SafetyEM-T3Expert Opinion on Drug Safety2025-06-131-9开放获取Safety and effectiveness of empagliflozin in Japanese patients with heart failure: a 1-year post-marketing surveillance study stratified by ageKazuhiro YamamotoNational Cerebral and Cardiovascular CenterYusuke NaitoBoehringer Ingelheim (Japan)Sakurako WatanabeBoehringer Ingelheim (Japan)去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词empagliflozinheart failureSGLT2 inhibitorsheart failure with reduced ejection fractionheart failure with preserved ejection fractionadverse drug reactionsdrug safetydrug effectivenessall-cause mortalitycardiovascular mortalityheart failure hospitalizationelderly patientsage-stratified analysisdehydrationblood pressure reductionpost-marketing surveillanceJapan参考文献32引证文献0相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
